The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications
Open Access
- 3 November 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (11) , e0164977
Abstract
Diagnoses of Type 1 Diabetes Mellitus (T1DM) in Europe appear to be on the rise. Therefore it is imperative that researchers understand the potential impact that increases in prevalence could have on the affected individuals as well as on society as a whole. Accordingly this study examined the humanistic and economic burden of T1DM in patients relative to those without the condition across a number of health outcomes including health status, work productivity loss, activity impairment, and healthcare resource use. Survey data from a large, representative sample of EU adults (The EU National Health and Wellness Survey) were examined. Results suggest that overall burden is higher for those diagnosed with T1DM than respondents without diabetes and that burden increases as complications associated with T1DM increase. Taken together, these results suggest that treatment strategies for T1DM should balance clinical, humanistic, and economic burden and patients should be educated on the role of complications in disease outcomes.Keywords
This publication has 25 references indexed in Scilit:
- Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literatureDiabetes Research and Clinical Practice, 2015
- Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysisThe Lancet Diabetes & Endocrinology, 2015
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2013
- Autoimmune Diabetes Inflames the HeartScience Translational Medicine, 2012
- Prediction model for the incidence and prevalence of type 1 diabetes in childhood and adolescence: evidence for a cohort-dependent increase within the next two decades in GermanyPediatric Diabetes, 2011
- Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important differenceCurrent Medical Research and Opinion, 2007
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine, 2005
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993
- Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987